Focus: Martin Pharmaceuticals is a drug repurposing specialist headquartered in New York focused on neurology and diagnostic applications. The company operates at an undisclosed scale with limited public visibility.
Profile data last refreshed 22h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow Martin Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Approved NDA product in peak revenue phase for diagnostic imaging applications.
Help build intelligence for Martin Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Martin Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Approved NDA product in peak revenue phase for diagnostic imaging applications.
Approved NDA product in peak revenue phase for diagnostic imaging applications.
Approved NDA product in peak revenue phase for diagnostic imaging applications.
Approved NDA product in peak revenue phase for diagnostic imaging applications.
Approved NDA product in peak revenue phase for diagnostic imaging applications.
Approved NDA product in peak revenue phase for diagnostic imaging applications.
NDA product transitioning toward full commercial potential in diagnostic imaging.
Approved NDA product in peak revenue phase for diagnostic imaging applications.
NDA product transitioning toward full commercial potential in diagnostic imaging.
No open positions listed yet.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moSource: USCIS H-1B Employer Data Hub